Finerenone Patent Expiration
Finerenone was first introduced by Bayer Healthcare Pharmaceuticals Inc
Finerenone Patents
Given below is the list of patents protecting Finerenone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kerendia | US8436180 | Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | Apr 12, 2029 | Bayer Hlthcare |
| Kerendia | USRE49826 | Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient | Jul 29, 2035 | Bayer Hlthcare |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳